产品名称：Human oxLDL Antibody (Okayama U. patent anti-oxLDL, Research Use)
产品编号：NBR-0761
针对靶点：oxLDL
抗体药商品名：Okayama U. patent anti-oxLDL
抗体药描述：The drug is a recombinant fully human anti-oxLDL monoclonal antibody, being developed by Okayama U. 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: OLR1
Synonyms: CLEC8A; LOX-1; SCARE1
Target Description: Receptor that mediates the recognition, internalization and degradation of oxidatively modified low density lipoprotein (oxLDL) by vascular endothelial cells. OxLDL is a marker of atherosclerosis that induces vascular endothelial cell activation and dysfunction, resulting in pro-inflammatory responses, pro-oxidative conditions and apoptosis.
Ensembl:  ENSG00000173391
Uniprot:  P78380